Innate Pharma (IPHYF)

OTC Markets


Symbol	Exchange	Currency
IPH	Paris	EUR	Real-time
IPHp	BATS Europe	EUR	Delayed
IPHA	NASDAQ	USD	Real-time
IPHYF	OTC Markets	USD	Delayed
IPH	TradeGate	EUR	Delayed

Currency in USD

Disclaimer

2.3000

0.0000(0.00%)

Closed22/08

Fair Value

Unlock Value

Day's Range

2.3000

52 wk Range

1.9301

2.8950

IPHYF Cash Flow Statement
Featured here, the Cash Flow Statement for Innate Pharma, showing the changes in the company's cash and cash equivalents, broken down to operating, investing and financing activities over each of the last 10 periods (either quarterly or annually).

Advanced Cash Flow Statement

Period Ending:

2014

31/12

2015

31/12

2016

31/12

2017

31/12

2018

31/12

2019

31/12

2020

31/12

2021

31/12

2022

31/12

2023

31/12

Cash from Operations

aa.aa

34.92

-51.77

-58.46

-19.16

-32.56

	Cash from Operations Growth
	Net Income
	Depreciation & Amortization, Total
	Amortization of Deferred Charges, Total
	Other Non-Cash Items, Total
	Change in Net Operating Assets

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	+207.36%	-248.23%	-12.92%	+67.23%	-69.97%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-20.76	-63.98	-52.81	-58.1	-7.57
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	16.53	13.27	4.6	4.41	5.09
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-1.09	48.16	-0.36	47.05	2.01
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	40.25	-49.21	-9.89	-12.5	-32.09

Cash from Investing

aa.aa

-62.12

-13.37

-0.92

1.88

20.63

	Cash from Investing Growth
	Capital Expenditure
	Sale of Property, Plant, and Equipment
	Cash Acquisitions
	Divestitures
	Other Investing Activities

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-355.86%	+78.48%	+93.14%	+304.69%	+999.15%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-1.27	-0.91	-0.93	-0.54	-0.35
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	0.01	0.01	-	0.15
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-60.85	-12.47	0.01	2.41	20.83

Cash from Financing

aa.aa

77.77

-1.18

26.82

-1.83

-1.97

	Cash from Financing Growth
	Total Debt Issued
	Short Term Debt Issued, Total
	Long-Term Debt Issued, Total
	Total Debt Repaid
	Short Term Debt Repaid, Total
	Long-Term Debt Repaid, Total
	Issuance of Common Stock
	Repurchase of Common Stock
	Issuance of Preferred Stock
	Repurchase of Preferred Stock
	Common & Preferred Stock Dividends Paid
	Special Dividend Paid
	Other Financing Activities
	Foreign Exchange Rate Adjustments
	Miscellaneous Cash Flow Adjustments

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	+27.02%	-101.51%	+2,378.59%	-106.82%	-7.55%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	13.9	1.36	28.7	-	-
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	13.9	1.36	28.7	-	-
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-1.98	-2.25	-2.07	-2.03	-2.36
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-1.98	-2.25	-2.07	-2.03	-2.36
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	66.05	0.05	0.5	0.2	0.4
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-0.2	-0.34	-0.31	-	-
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	0.01	0.22	-0.48	-0.43	0.27
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-0	-0	0	-

Net Change in Cash

aa.aa

50.57

-66.1

-33.04

-19.53

-13.62

	Beginning Cash Balance
	Ending Cash Balance
	Levered Free Cash Flow
	Levered Free Cash Flow Growth
	Free Cash Flow Yield

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	152.31	202.89	136.8	103.76	84.22
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	202.89	136.79	103.76	84.23	70.61
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	13.48	-74.5	-15.02	-32.74	-27.07
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	+246.52%	-652.45%	+79.84%	-118.04%	+17.33%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-6.99%	-19.11%	-17.28%	-7.79%	-15.28%

* In Millions of EUR (except for per share items)

US 30

41,395.00

+298.2

+0.73%

US 500

5,622.60

+26.8

+0.48%

Dow Jones

41,393.78

+297.01

+0.72%

S&P 500

5,626.02

+30.26

+0.54%

Nasdaq

17,683.98

+114.30

+0.65%

S&P 500 VIX

16.56

-0.51

-2.99%

Dollar Index

101.12

-0.230

-0.23%

Market Movers

Name	Last	Chg. %	Vol.
NVDA	119.10	-0.03%	238.36M
TSLA	230.29	+0.21%	59.52M
AAPL	222.50	-0.12%	36.77M
AVGO	167.69	+1.90%	29.85M
MSFT	430.59	+0.84%	15.87M
ADBE	536.87	-8.47%	10.42M
META	524.62	-0.19%	10.32M

Name	Last	Chg. %	Vol.
WBD	8.49	+10.84%	57.72M
VFC	18.70	+8.47%	5.88M
ETSY	55.65	+7.56%	6.20M
ALGN	243.73	+6.50%	887.46K
UBER	72.48	+6.45%	30.38M
CZR	38.87	+6.41%	5.29M
ARM	147.37	+5.88%	10.88M

Name	Last	Chg. %	Vol.
ADBE	536.87	-8.47%	10.42M
GRMN	172.68	-5.13%	2.02M
BA	156.77	-3.69%	19.00M
NSC	245.80	-3.45%	2.45M
FSLR	228.79	-3.03%	2.18M
PDD	94.99	-2.40%	16.29M
MRNA	68.28	-2.01%	11.45M

Trending Stocks

Name	Last	Chg. %	Vol.
NVDA	119.10	-0.03%	238.36M
TSLA	230.29	+0.21%	59.52M
ADBE	536.87	-8.47%	10.42M
BA	156.77	-3.69%	19.00M
SMCI	457.16	+3.40%	7.00M

Popular Searches

Please try another search

Innate Pharma (IPHYF)

IPHYF Cash Flow Statement
Featured here, the Cash Flow Statement for Innate Pharma, showing the changes in the company's cash and cash equivalents, broken down to operating, investing and financing activities over each of the last 10 periods (either quarterly or annually).

Trending Stocks

Please try another search

Innate Pharma (IPHYF)

IPHYF Cash Flow StatementFeatured here, the Cash Flow Statement for Innate Pharma, showing the changes in the company's cash and cash equivalents, broken down to operating, investing and financing activities over each of the last 10 periods (either quarterly or annually).

Trending Stocks

IPHYF Cash Flow Statement
Featured here, the Cash Flow Statement for Innate Pharma, showing the changes in the company's cash and cash equivalents, broken down to operating, investing and financing activities over each of the last 10 periods (either quarterly or annually).